MCM
GILD icon

Monarch Capital Management’s Gilead Sciences GILD Stock Holding History

Monarch Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.14M Buy
40,685
+578
+1% +$76.2K 1.18% 28
2026
Q1 		$5.59M Sell
40,107
-3,420
-8% -$479K 1.37% 24
2025
Q4 		$5.34M Sell
43,527
-687
-2% -$83.5K 1.31% 26
2025
Q3 		$4.91M Sell
44,214
-435
-1% -$49.4K 1.2% 27
2025
Q2 		$4.95M Sell
44,649
-40
-0.1% -$4.26K 1.33% 28
2025
Q1 		$5.01M Sell
44,689
-2,390
-5% -$247K 1.39% 28
2024
Q4 		$4.35M Sell
47,079
-840
-2% -$75.6K 1.19% 29
2024
Q3 		$4.02M Sell
47,919
-297
-0.6% -$22.7K 1.08% 32
2024
Q2 		$3.31M Sell
48,216
-678
-1% -$45.2K 0.97% 35
2024
Q1 		$3.58M Sell
48,894
-331
-0.7% -$25.5K 1.01% 35
2023
Q4 		$3.99M Sell
49,225
-798
-2% -$62.1K 1.21% 31
2023
Q3 		$3.75M Sell
50,023
-955
-2% -$73.5K 1.2% 30
2023
Q2 		$3.93M Sell
50,978
-1,443
-3% -$115K 1.19% 33
2023
Q1 		$4.35M Sell
52,421
-780
-1% -$64.6K 1.34% 30
2022
Q4 		$4.57M Sell
53,201
-5,220
-9% -$413K 1.4% 30
2022
Q3 		$3.6M Sell
58,421
-1,428
-2% -$90K 1.17% 34
2022
Q2 		$3.7M Sell
59,849
-90
-0.2% -$5.57K 1.1% 37
2022
Q1 		$3.56M Sell
59,939
-694
-1% -$44.4K 0.94% 39
2021
Q4 		$4.4M Buy
60,633
+400
+0.7% +$27.6K 1.13% 36
2021
Q3 		$4.21M Sell
60,233
-4,320
-7% -$303K 1.17% 35
2021
Q2 		$4.45M Buy
64,553
+5
+0% +$334 1.27% 33
2021
Q1 		$4.17M Sell
64,548
-2,821
-4% -$182K 1.24% 31
2020
Q4 		$3.92M Buy
67,369
+1,888
+3% +$114K 1.24% 31
2020
Q3 		$4.14M Buy
65,481
+747
+1% +$51.8K 1.44% 28
2020
Q2 		$4.98M Sell
64,734
-2,382
-4% -$183K 1.82% 24
2020
Q1 		$5.02M Buy
67,116
+8,728
+15% +$603K 2.05% 19
2019
Q4 		$3.79M Buy
58,388
+2,800
+5% +$182K 1.24% 35
2019
Q3 		$3.52M Buy
55,588
+668
+1% +$43.7K 1.23% 35
2019
Q2 		$3.71M Buy
54,920
+1,491
+3% +$98.1K 1.33% 32
2019
Q1 		$3.47M Buy
53,429
+3,622
+7% +$241K 1.26% 34
2018
Q4 		$3.12M Sell
49,807
-2,980
-6% -$208K 1.26% 33
2018
Q3 		$4.08M Sell
52,787
-2,165
-4% -$164K 1.48% 30
2018
Q2 		$3.89M Buy
54,952
+203
+0.4% +$14.3K 1.49% 28
2018
Q1 		$4.13M Buy
54,749
+810
+2% +$64.4K 1.59% 28
2017
Q4 		$3.86M Sell
53,939
-1,620
-3% -$123K 1.44% 29
2017
Q3 		$4.5M Buy
55,559
+3,975
+8% +$304K 1.68% 27
2017
Q2 		$3.65M Buy
51,584
+2,885
+6% +$192K 1.38% 31
2017
Q1 		$3.31M Buy
48,699
+10,620
+28% +$747K 1.21% 35
2016
Q4 		$2.73M Buy
38,079
+14,014
+58% +$1.04M 1.02% 39
2016
Q3 		$1.9M Buy
24,065
+12,160
+102% +$988K 0.72% 43
2016
Q2 		$993K Buy
11,905
+3,240
+37% +$288K 0.37% 58
2016
Q1 		$796K Buy
+8,665
New +$781K 0.29% 65

Other funds holding GILD

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Monarch Capital Management's GILD Position: Q2 2026 in Review

Monarch Capital Management increased its Gilead Sciences (GILD) stake by 1.4% in Q2 2026, buying an estimated $76.2K and bringing the position to 40,685 shares worth $5.14M. The position accounts for 1.18% of the portfolio, ranked #28.

Monarch Capital Management first reported a position in GILD in Q1 2016 and has held it in 42 quarters since. The position peaked at $5.59M in Q1 2026. 1,032 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Monarch Capital Management held 40,685 shares of Gilead Sciences worth $5.14M as of Q2 2026.
  • Monarch Capital Management bought 578 Gilead Sciences shares in Q2 2026, an estimated $76.2K.
  • Gilead Sciences made up 1.18% of Monarch Capital Management's portfolio in Q2 2026, its #28 holding.
  • Monarch Capital Management first reported a position in Gilead Sciences in Q1 2016 and has held it in 42 quarters since.
  • Monarch Capital Management's Gilead Sciences position peaked at $5.59M in Q1 2026.
  • 1,032 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Monarch Capital Management's 13F filing for Q2 2026, filed 22 Jul 2026.